Rafferty Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $5.68M | Sell |
|
|||||
|
2023
Q2 | $4.56M | Buy |
|
|||||
|
2023
Q1 | $3.5M | Sell |
|
|||||
|
2022
Q4 | $3.29M | Buy |
|
|||||
|
2022
Q3 | $3.15M | Buy |
|
|||||
|
2022
Q2 | $2.12M | Sell |
|
|||||
|
2022
Q1 | $3.71M | Sell |
|
|||||
|
2021
Q4 | $4.23M | Buy |
|
|||||
|
2021
Q3 | $2.19M | Buy |
|
|||||
|
2021
Q2 | $2.42M | Sell |
|
|||||
|
2021
Q1 | $3.66M | Buy |
|
|||||
|
2020
Q4 | $750K | Sell |
|
|||||
|
2020
Q3 | $1.97M | Buy |
|
|||||
|
2020
Q2 | $609K | Buy |
|
|||||
|
2020
Q1 | $243K | Sell |
|
|||||
|
2019
Q4 | $4.07M | Sell |
|
|||||
|
2019
Q3 | $6.24M | Buy |
|
|||||
|
2019
Q2 | $4.95M | Buy |
|
|||||
|
2019
Q1 | $5.5M | Buy |
|